5 Takeaways From FDA's Off-Label Promotion Guidance
New guidance from the U.S. Food and Drug Administration clarifies how drugmakers and device makers can avoid illicit off-label marketing when sharing scientific literature about unapproved uses of their products, scrubbing...To view the full article, register now.
Already a subscriber? Click here to view full article